Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,110.00
+190.00 (3.21%)
May 21, 2026, 11:49 AM KST
Market Cap137.68B -27.6%
Revenue (ttm)n/a +13,737.3%
Net Incomen/a
EPSn/a
Shares Out23.26M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume43,570
Average Volume151,174
Open5,920.00
Previous Close5,920.00
Day's Range5,920.00 - 6,170.00
52-Week Range5,910.00 - 11,520.00
Beta0.82
RSI19.78
Earnings Daten/a

About Vaxcell-Bio Therapeutics

Vaxcell-Bio Therapeutics Co., Ltd. develops and anticancer immunotherapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 323990
Full Company Profile

Financial Performance

In 2024, Vaxcell-Bio Therapeutics's revenue was 1.90 billion, an increase of 13737.28% compared to the previous year's 13.72 million. Losses were -10.62 billion, 3.40% more than in 2023.

Financial Statements